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Abstract
Objectives: To estimate the incidence of avoidable significant harm in primary care in 
England; describe and classify the associated patient safety incidents, and generate 
suggestions to mitigate risks of ameliorable factors contributing to the incidents.
Design: Retrospective case note review. Patients with significant health problems were 
identified and clinical judgements made on avoidability and severity of harm. Factors 
contributing to avoidable harm were identified and recorded.  
Setting: Primary care.
Participants: Thirteen general practitioners undertook a retrospective case note review of a 
sample of 14,407 primary care patients registered with 12 randomly selected general 
practices from three regions in England (total list size: 92,255 patients). 
Main Outcome Measures: The incidence of significant harm considered at least ‘probably 
avoidable’ and the nature of the safety incidents. 
Results: The rate of significant harm considered at least ‘probably avoidable’ was 35.6 
(95%CI: 23.3-48.0) per 100,000 patient-years (57.9 (95% CI: 42.2-73.7) per 100,000 based 
on a sensitivity analysis). Overall, 74 cases of avoidable harm were detected involving 72 
patients. Three types of incident accounted for more than 90% of the problems: problems 
with diagnosis accounted for 45/74 (60.8%) primary incidents, followed by medication-
related problems (n=19; 25.7%) and delayed referrals (n=8; 10.8%). In 59 (79.7%) cases, 
the significant harm could have been identified sooner (n=48) or prevented (n=11), if the GP 
had taken actions aligned with evidence-based guidelines.
Conclusions: 
There is likely to be a substantial burden of avoidable significant harm attributable to primary 
care in England with diagnostic error accounting for most harms. Based on the contributory 
factors we found, improvements could be made through more effective implementation of 
existing information technology; enhanced team coordination and communication, and 
greater personal and informational continuity of care.
Word count: 280
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Introduction
Healthcare-associated harm is an internationally recognised threat to public health and 
wellbeing. As many countries, across all income settings, aspire towards universal health 
coverage, attention has focused on the critical role of primary care-led health care systems 
to help achieve this goal.1,2 In countries like the United Kingdom (UK), over 90% of clinical  
encounters are delivered in community settings,3 but a clear understanding of avoidable 
harm is needed to enable health care systems to identify and learn from the most serious 
incidents and the factors amenable to intervention. 
Most patient safety research has focused on hospital-based care settings resulting in a 
greater awareness of the frequency and causes of health care-associated errors, and the 
resulting burden to patients.4 Patient safety research in primary care has been slower2,5 
although the profile of patie t safety in primary care was provided a platform by the World 
Health Organization’s (WHO) Safer Primary Care Expert Group (2012), and catalysed by 
more recently by the US National Patient Safety Foundation’s call to look ‘beyond hospitals 
to the full care continuum’ and the OECD’s assessment of the economic burden of unsafe 
primary and ambulatory care.6-8 The WHO’s Technical Series for Safer Primary Care, where 
world experts have explored the existing evidence base for primary care safety, highlighted 
that major evidence gaps exist and robust high-quality epidemiological studies are needed to 
definitively establish the burden of unsafe primary care.9 Whilst harm from hospital-based 
care may be more visible, given the volume of patient consultations that occur in primary 
care, the aggregate burden of harm cannot be ignored.7
Our WHO-commissioned systematic review investigating the frequency and burden of harm 
in general practice concluded 2–3% of primary care encounters involved a patient safety 
incident, and around one in 25 of those resulted in a significant harm outcome that has a 
substantial impact on a patient’s well-being.8 Included studies were notably heterogeneous 
in study design and definitions of outcome measures. None of the primary care studies in 
this, or our subsequent systematic review,10 reported the incidence of avoidable harm11,12 
based on independent review of medical records, and few distinguished between minor and 
more significant harms.13 Also, we are aware of only one previous study that was large 
enough to identify substantial numbers of significant harms, but it did not report on these in 
detail.13 This means that based on the literature it has not been possible to reliably quantify 
the overall burden of avoidable significant patient harm in primary care. 
We have addressed this issue in the current study by undertaking a large retrospective case 
note review study, using independent clinical reviewers, to: 1) estimate the incidence of 
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avoidable significant harm in primary care in England; 2) quantify, describe and classify the 
patient safety incidents that result in avoidable significant harm (thus showing the top 
categories of avoidable harm) and 3) generate suggestions to mitigate risks of ameliorable 
factors that contributed to the incidents. Our study is different to other primary care studies 
because of its specific focus on identifying and understanding significant harm, and because 
have estimated the incidence (rather than prevalence) of harm on the basis that this 
provides policy makers with a better idea of the potential burden of the problem. We have 
used a definition of avoidable harm based on a consensus study panel with general 
practitioners,14 using real cases of unsafe general practice from our earlier national-level 
analysis of patient safety incident reports.15 
Methods
Our study protocol describes the methods we employed in detail,16 and an expanded version 
of our methods is in the supplementary materials. Box 1 provides the definitions used in the 
study. The study had NHS research ethics committee approval (15/EM/0411). 
Participants
We used a stratified random sampling approach to invite general practices to participate 
from three different areas of England. We undertook a retrospective case note review of an 
open cohort of all primary care patients registered with participating general practices 
(between 1 April 2015 and 31 March 2016) to identify cases of avoidable significant harm. 
Recruitment and training of data collectors
General practitioners with at least five years’ experience in general practice were recruited to 
collect data from the participating practices, and were provided with training.16
Sampling of patient records
We sampled patient records in three stages. In Stage 1, we identified the total patient 
population of the practices at the start of the retrospective cohort (1 April 2015). In Stage 2, 
we used electronic registry queries to identify patients at increased risk of significant health 
problems and/or avoidable significant harm (the ‘enhanced sample’). Drawing on 
suggestions made by the research commissioners, the literature on avoidable harm in 
primary care8 and our own experience of analysing reports of harm associated with primary 
care,15 we included patients who had: died17 been admitted to secondary care18 were 
resident in a care home;19 had multimorbidity15 or polypharmacy,20,21  had undergone an 
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invasive procedure in general practice22 or had been certified unfit for work long-term. In 
Stage 3, one of the GP data collectors screened the electronic health record of each patient 
in the ‘enhanced sample’ to identify any new significant health problems experienced by 
patients over the 12 months of the study (1 April 2015 – 31 March 2016). The GPs then 
undertook detailed retrospective reviews of the records of this final sample of patients to 
identify the extent to which errors in primary healthcare provision contributed to these 
problems. 
For the purposes of sensitivity analysis (recognising that cases might have been missed by 
our sampling approach), the GP data collectors also undertook a detailed records review for 
the following:
 2.5% random sample of the Stage 1 population, not including patients identified for the 
Stage 2 enhanced sample; each record was examined by a single GP reviewer.
 10% random sample of the Stage 2 enhanced sample; each record was examined by a 
second GP reviewer.
Identification of avoidable significant harm, and factors associated with this
For those patients with significant health problems, the GP data collectors recorded whether 
they found any evidence of avoidable harm. If so, the GPs provided a detailed written 
account of the principal problem in the patient’s primary care that led to the significant health 
problem, a narrative describing the manner in which the significant health problem could 
have potentially been prevented within primary care, and a judgement on the avoidability of 
the significant health problem using a validated six-point scale (see Box 2).17,23 All cases 
were considered in detail by the study team, and the GP data collectors were asked to 
provide additional information if any clarification were needed. To ensure consistency the 
study team made the final judgement, through consensus, in terms of the classification of 
avoidable significant harm. 
Data collection and coding
Each of the participating general practices was visited by an informatician from the study 
team who collected baseline data on the practice population and ran a computer search to 
identify patients for the enhanced sample and for the sensitivity analyses. Using encrypted 
tablet computers and a Virtual Private Network (VPN) connection, the GP data collectors 
entered anonymised data directly into a database on a secure server at Cardiff University. 
The nature of the avoidable harm was recorded by the GP data collectors using the 
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comprehensive patient safety classification system developed in the Primary Care Patient 
Safety Classification (PISA) study.24
Analysis
We estimated the incidence of significant harm that was considered at least probably 
avoidable (our primary outcome – avoidability score 4 or more) and at least possibly 
avoidable (avoidability score 3 or more) accompanied by 95% confidence intervals (95% 
CI).16 We assessed inter-rater reliability of judgements made using the Cohen’s Kappa 
statistic (with 95% CI). 
Members of the study team then undertook a detailed analysis of the information provided 
on each case of potentially avoidable significant harm and included cases with at least ‘slight 
to modest’ (score 2 or more) evidence of avoidability, as we judged that even in these cases 
there were important insights. We analysed the data recorded on the cases and examined 
the relationships between different types of incident and the factors that contributed to these 
incidents. As a result, we identified the most important factors contributing to avoidable 
significant harm.
Results
Twelve practices were recruited (as shown in Figure 1) and Table 1 shows their 
characteristics compared with national averages for England. The practices were similar to 
the English average in terms of list size, Index of Multiple Deprivation, and age and gender 
of patients, but had a higher percentage of non-White patients. Also, all the participating 
practices were rated overall as ‘good’ or ‘outstanding’ by the CQC, whereas almost 12% of 
the practices in England received ‘inadequate’ or ‘requires improvement’ scores.
The total list size for the 12 general practices at the start date of the study cohort (1 April 
2015) was 92,255 (Stage 1). The total number of patient-years of clinical data available for 
the 92,255 patients over the year of the cohort (1 April 2015 - 31 March 2016) was 89,779.
The flow of patient records through the study is shown in Figure 2. The computer searches 
identified 12,080 patients (13.1%) for the enhanced sample (Stage 2). Their records were all 
examined by at least one GP data collector (first GP data collector in Figure 2), and 1,271 
(10.5% random sample) were examined independently by a second GP data collector. From 
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the Stage 1 population of 92,255, a random sample of 2,327 (2.5%) patients (but not 
included in the enhanced sample) was examined by one of the GP data collectors. 
Based on the assessment of the GP data collector doing the first assessment on the 
enhanced sample, there were 2,131 new significant health problems for 2,116 patients 
between 1 April 2015 and 31 March 2016 (Stage 3 – see Figure 2). For 2,054 (96.4%) of the 
significant health problems, the GP data collector judged that the patient had received an 
adequate standard of care and therefore classified these cases as having ‘virtually no 
evidence of avoidability’. 
For the remaining 77 (3.6%) cases, the first GP reviewer formally assessed avoidability and 
the distribution of avoidability scores, following moderation by the study team, is shown in 
Table 2. A further 10 cases had ‘virtually no evidence of avoidability’, meaning that in total 
2,064 (96.9%) of the 2,131 significant health problems were considered unavoidable in 
primary care. 
There were 32 cases (1.5%) of significant harm considered to be at least probably avoidable 
and 51 (2.4%) considered at least possibly avoidable. This translates into a rate of 35.6 per 
100,000 patient-years (95% CI: 23.3-48.0) for significant harm considered at least probably 
avoidable and 56.8 per 100,000 patient-years (95% CI: 41.2-72.4) at least possibly 
avoidable. 
Sensitivity analysis
The examination of the 2.5% sample of the patient population did not identify any additional 
cases of significant harm considered at least possibly avoidable. The examination of the 
10% sample of the enhanced sample by a second GP reviewer identified two further cases 
of significant harm considered to be at least probably avoidable and four cases considered 
at least possibly avoidable, based on the final judgement of the study team. This means that 
had all the patient records in the enhanced sample been assessed independently by two 
GPs, there could have been an additional 20 cases considered at least probably avoidable, 
and 40 cases of significant harm considered at least possibly avoidable. In the sensitivity 
analysis, this translated into rates of 57.9 (95% CI: 42.2-73.7) per 100,000 patient-years for 
significant harm considered at least probably avoidable, and 101.4 (95% CI: 80.5-122.2) per 
100,000 patient-years for significant harm considered at least possibly avoidable.
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Interrater reliability
Where an assessment of avoidability was done, there was 77.0% agreement between GP 
data collectors and the study team about whether the case was considered at least possibly 
avoidable (Cohen’s Kappa: 0.49 (95% CI: 0.29-0.69). For the 10% sample of the enhanced 
sample, there was 71.5% agreement between the first and second GP reviewer that a 
patient had at least one significant health problem (Kappa: 0.33 (95% CI: 0.27-0.38), and 
where an avoidability assessment was done independently by two GP data collectors, there 
was a 67.6% agreement about whether the significant harm was considered at least possibly 
avoidable (Kappa: 0.34 (95% CI: 0.02-0.66)). 
Analysis of the nature and causes of avoidable significant harm
For the detailed analysis of the nature and causes of avoidable significant harm, we included 
74 cases involving 72 patients. The distribution of avoidability scores for these cases is 
shown in Table 3. 
The distribution of different types of primary incidents for the 74 cases is shown in Table 4, 
with problems with diagnosis accounting for 60.8%; medication-related problems for 25.7% 
and delayed referrals for 10.8% (the latter relating to situations where a clinician had 
decided that a referral was needed, but there was such a delay in the referral being made 
that the patient may have been harmed as a result). Examples of these incidents are shown 
in Box 3 and Box 4. In relation to the 74 primary incidents, 114 underlying ‘contributory 
factors’ were identified, and these are shown in Table 5. Patient factors accounted for 
71.9%, with co- or multi-morbidities the most important categories (24.6% of all contributory 
factors), whilst 17.5% of factors included issues such as not taking medicines as prescribed, 
problems with eliciting relevant information from patients or caregivers, not following medical 
advice, and presenting with multiple issues in a single consultation. Factors such as 
multimorbidity and frailty contributed either through offering alternative explanations for 
symptoms or by presenting clinicians with multiple competing demands. Organisational 
factors accounted for 21.1% of contributory factors whilst staff factors such as inadequate 
knowledge, skills or mistakes by healthcare professionals accounted for 7.0%. In 59 (79.7%) 
of the 74 cases, the significant harm could have been identified sooner (48 cases), or 
prevented (11 cases), if the GP had taken actions aligned with evidence-based guidelines 
(see examples in Box 3).
Page 9 of 45
https://mc.manuscriptcentral.com/bmjqs
BMJ Quality & Safety
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
9
These 74 cases involved 115 healthcare professionals (81 (70.4%) GPs and 10 (8.7%) 
practice nurses), and only four of these (3.5%) were clearly identifiable as being from 
outside the participating general practices (community nurse, community optometrist, 
community physiotherapist, community psychiatric nurse).
Discussion
Principal findings
The estimated incidence of significant harm in English primary care considered at least 
‘probably’ avoidable is between 35.6 and 57.9 per 100,000 patient-years (the latter figure 
being based on sensitivity analysis). Extrapolating our findings to the English population of 
55.6 million (mid-year 2017), there are likely to be between 19,800 and 32,200 cases of 
‘probably avoidable’ significant harm to patients each year. 
The three major sources of significant avoidable harm in general practice were diagnostic 
error (60.8% of the avoidable incidents), medication incidents (25.7%) and delayed referrals 
(10.8%). In 79.7% of cases, the significant harm could have been identified sooner, or 
prevented, if the GP had taken actions aligned with evidence-based guidelines. The study 
identified a mix of organisational, clinician and patient contributory factors associated with 
the avoidable incidents. The majority of these were patient factors (71.9% of the total 
contributory factors identified) including multimorbidity, old age and complexity arising from 
pathophysiological factors such as frailty. Most of these factors are not ameliorable, but 
highlight the challenges that healthcare professionals face when trying to avoid patients 
coming to harm. Of the organisational factors, problems relating to continuity and co-
ordination of care (between providers and within primary care) were most important (14.1% 
of the total). For example: patient did not experience a ‘seamless service’ due to failures in 
coordination and sharing of information between different providers across the health and 
social care system; disconnect between multiple members of the primary care in the same 
practice; and lack of care coordination as a patient transitions from secondary back to 
primary care. Mitigating risk for future patients could be achieved through targeting the 
organisational structures and processes underpinning the most frequent contributing factors.
Strengths and limitations of the study
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This is one of the most comprehensive studies of avoidable harm in primary care,8,10 and 
one of only two records review studies we are aware of that is large enough to report on 
substantial numbers of significant harms.13 It is the only study of which we are aware that 
has reported the incidence of avoidable harm based on independent review of primary care 
clinical records.  In terms of other potential methods of investigation, independent 
retrospective case note review has significant advantages over incident reports, which are 
more at risk of selection bias and are not well suited to accurately estimating the incidence 
of avoidable harm. It also has advantages over database studies, because detailed 
examination is required of the healthcare records (including hospital correspondence) that is 
not possible through clinical databases. One major limitation of case note review is the 
onerous task of searching for and identifying important information to build a narrative, 
based on what is explicitly stated or from what is absent based on the clinician’s knowledge 
of the relevant evidence-based guidelines. 
We used a stratified random sampling approach to recruit 12 general practices from three 
geographically different regions of England, and the independent GPs involved in data 
collection were experienced and were given thorough training. We used a validated method 
for judging the avoidability of harm,14 and a comprehensive validated system for classifying 
the underlying causes of patient harm.15 Our methodological approach used the Recursive 
Model of Incident Analysis and permitted us to capture the series of ‘contributing incidents’ 
that led to the final ‘principal incident’ prior to the patient experiencing a harmful outcome.25 
This meant we could provide the most robust and comprehensive assessment of the patient 
safety incidents implicated in significant avoidable harm outcomes, as well as consider the 
apparent underlying events when formulating our recommendations to mitigate future risk to 
patients. 
Only a quarter of the general practices in the stratified random sample agreed to participate 
and this is a limitation from an epidemiological perspective.  The most common reason cited 
for not participating was lack of time. Although the characteristics of the practices recruited 
were similar to those in England in most respects, none of the study practices received an 
overall CQC rating of ‘inadequate’ or ‘requires improvement’, whereas 2.6% and 9.1% 
(respectively) of all English practices received these ratings. If CQC ratings are associated 
with patient safety, then our study may underestimate the overall incidence of avoidable 
significant harm in English general practices. Our inter-rater reliability assessments showed 
that there was moderate agreement between the GPs in their identification of patients with 
significant health problems, and their judgements as to whether a patient had experienced 
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avoidable significant harm. Even with our sensitivity analysis, the upper limit of our estimates 
of the incidence of avoidable significant harm may be an underestimate. This highlights the 
uncertainties of estimates of frequency of harm originating from case note reviews that rely 
on clinical judgement. It suggests that our study could have missed some cases of avoidable 
significant harm but could also have included cases that others might not consider to be 
‘significant’ or ‘avoidable’.
Through our ‘enhanced sample’ we successfully identified patients most likely to have 
avoidable significant harm, but the criteria we used might be difficult to replicate in other 
countries. We did however manage to identify these patients through electronic medical 
records, and so a similar approach should be possible in countries with comprehensive 
primary care electronic r cords. Our study was not designed to detect near misses.
Comparison with other studies
We recognise from our previous systematic reviews,8,10 that comparing studies of avoidable 
harm is difficult because of different study designs and different ways of applying definitions 
of avoidable harm. One key difference between our study and almost all previous studies is 
that we report the incidence of avoidable harm rather than the prevalence (per consultation). 
Our approach allows for a clearer estimate of the public health burden of avoidable harm, 
while also recognising that some harms, especially in a primary care setting, may occur over 
several consultations (e.g. delayed diagnosis). Also, we have focused specifically on 
‘significant’ harm (such as a clinically important delay in cancer diagnosis) to ensure that our 
findings reflect a health burden that is unquestionably of importance to patients, the public, 
clinicians and policymakers. 
The only study we are aware of that was of a similar large size to ours, while also reporting 
on severity, was from a convenience sample of 48 health centres in Spain with health 
professionals reporting any incidents causing harm.13 From 96,047 consultations, 773 harms 
were detected with 46 of these considered ‘severe’. Of all the harms, 64.3% were 
considered preventable, and applying this percentage to the severe harms suggests a 
prevalence of 30.8 severe harms per 100,000 consultations. It is not possible to directly 
compare this with the incidence figures from our study (where the same harm may have 
been apparent across several consultations over the course of the 12 months), but the 
overall rates of significant harm are probably not widely dissimilar.
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There is considerable variation in studies reporting categories of avoidable harm as well as 
contributory factors. Nevertheless, our findings are in keeping with a systematic review that 
found that diagnostic errors were among the most important causes of avoidable harm,10 
and a review of the global burden of diagnostic errors in primary care,26 while the systematic 
review10 (and other studies) have highlighted the importance of prescribing errors.13 In 
relation to diagnostic delay in cancer, a recent study has highlighted that in almost half of 
cases this is attributable to primary care,27 with problems with clinical appraisal of the patient 
and referral being particularly important. Our study has specifically highlighted the 
importance of delays in making a referral,15,23 and this has been highlighted as an important 
problem by the Institute for Healthcare Improvement.28 In comparison with other studies, 
ours is unusual in reporting such a high level of patient factors contributing to patient harm. 
While many of these cannot be considered the reason for the harm being avoidable, the 
findings suggest that factors such as multimorbidity, frailty and complex presentations may 
make it more difficult for clinicians to make timely and accurate diagnosis and avoid 
medication errors. In relation to contributory factors that are avoidable, our findings are in 
keeping with other studies that have highlighted organisational issues and communication 
problems.8,12,29 
Implications for clinicians and policy makers
This study has estimated the incidence of significant harm in English primary care 
considered at least ‘probably’ avoidable, which translates to 3-4 cases per year for an 
average general practice of 8,000 patients. Efforts to make improvements should focus on 
addressing the structures and processes underpinning the identified patient, clinician and 
organisational contributing factors. For example, better organisation of key systems (e.g. 
referrals, test result management, identifying non-adherence) and related administration 
could have prevented most incidents. Some of the earliest patient safety studies carried out 
in primary care over two decades ago pointed to administrative failures, such as the 
mismanagement of test results, as the root cause of the commonest incidents concerning 
diagnosis and medication,30-32 and an Australian study concluded about 70% of incidents 
were related to processes of providing healthcare, rather than gaps in the knowledge and 
skills of health professionals.11 The current study provides considerable insights into the 
ameliorable contributory factors associated with avoidable significant harm in primary care, 
which in turn have generated the following suggestions for improvement.
More effective implementation of existing information technology solutions could ensure that 
planned action such as referrals take place in a timely way.26 Enhanced team coordination 
Page 13 of 45
https://mc.manuscriptcentral.com/bmjqs
BMJ Quality & Safety
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
13
and communication could ensure that patients are seen (or have necessary investigations), 
or that they are recalled for follow-up investigations or assessment, when needed. Currently 
it is largely down to individual primary care teams, and individual healthcare practitioners, to 
develop their own strategies. Without stifling innovation, however, it might be helpful to 
model ‘what best practice looks like’ in relation to preventing patients from coming to harm. 
Interventions like the ‘QRISK®3-2018’ algorithm to calculate a person’s risk of developing a 
‘heart attack’ or stroke are now commonly integrated into electronic health record systems 
and used by clinicians to explain and manage risk and support patient decision-making.33 In 
a similar way, the factors implicated in patient safety incidents that we have identified might 
be considered as signals for future algorithms for development and validation, either to flag 
up patients for timely clinical review to mitigate current risk levels or to proactively detect 
risks of future unsafe care. 
 
Our study suggests that lack of continuity of care may contribute to avoidable significant 
harm in some cases.34 Recent systematic reviews suggest that low continuity of care is 
associated with a higher risk of mortality across different healthcare settings,35 and 
specifically in general practice.36 In some cases in our study, follow up by the same primary 
healthcare practitioner could have been helpful to enable earlier recognition of the 
progression of a serious health problem. In other cases, better ‘informational continuity’37 
could have helped to ensure that the assessment and suggested follow-up plans from a 
previous consultation better informed the next consultation. This should be facilitated by 
electronic health records, but we found several examples where recommendations from one 
consultation were not acted upon in a subsequent consultation involving a different 
healthcare practitioner. Nevertheless, high levels of personal continuity may not always be 
best for patients. A recent study qualitative showed a mixed picture in terms of patients’ 
perceptions of whether personal continuity improved safety, or not,38 while a cross-sectional 
ecological study found that general practices that appeared to have high levels of personal 
continuity, did fewer urgent referrals;39 this does not necessary mean they were less safe, 
but it is a potential cause for concern.
Some of the cases of avoidable significant harm in our study were associated with GPs 
having too many problems to deal with adequately in a single consultation, with significant 
health problems not detected early enough because of lack of effective and timely clinical 
history taking, examination or investigation. Some of the contributory factors associated with 
patient behaviours may have resulted from their concerns being unrecognised or 
unresolved, as highlighted in a study of missed opportunities in cancer diagnosis.40 When 
such incidents occur in general practice, it is essential that practice teams know how to 
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generate learning from the incident, including how to identify vulnerabilities in their existing 
structures and processes, and feel confident to plan and test changes that could achieve 
improved outcomes for future patients.41 The introduction of quality improvement domains 
into 2019/20 Quality and Outcomes Framework by NHS England represents a promising 
commitment for supporting practices to learn about and develop their approach to systems 
improvement42 as does the 2019 NHS Patient Safety Strategy.43
Conclusion 
There is likely to be a substantial burden of avoidable significant harm attributable to primary 
care in England with diagnostic error accounting for most harms, followed by medication 
error and delays in making a referral once a referral decision had been made. Based on the 
contributory factors we found, improvements could be made through more effective 
implementation of existing i formation technology; enhanced team coordination and 
communication, and greater personal and informational continuity of care.
Word count for the manuscript following editing of text in the methods section (full 
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Box 1: Definitions used in our study
Significant harm
Our definition of significant harm was informed by the international classification of 
patient safety definitions of moderate harm, severe harm and death outcomes.44 The 
definition used was as follows:
‘A patient outcome is symptomatic, which required more intensive intervention than 
might otherwise have been required (eg, additional operative procedure) and 
resulted in an escalation of care (eg, hospital admission), or death. This caused a 
loss of function of at least one bodily organ, which may have been a temporary or 
permanent loss of its function’
Avoidability
Our definition of avoidability was informed by our RAND / UCLA appropriateness 
methods study14 to contextualise our definition of significant harm. The definition 
used was as follows:
‘a patient safety incident could have probably, or totally been avoided by the timely 
intervention of a health care professional in family practice (e.g. investigations, 
treatment, safety netting) and / or an administrative process (e.g. referrals, alerts in 
electronic health records, procedures for following up results) in accordance with 
accepted standards of evidence-based practice and / or clinical governance and / or 
the Bolam test.’44
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Box 2: Six-Point Avoidability Scale 17,23
Rating Category Description
1 Totally unavoidable Virtually no evidence of avoidability
2 Unavoidable Slight to modest evidence of avoidability
3 Possibly avoidable Possibly avoidable, less than 50-50, but close call
4 Probably avoidable Probably avoidable, more than 50-50, but close call
5 Probably avoidable Strong evidence of avoidability
6 Totally avoidable Virtually certain evidence of avoidability
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Table 1: Characteristics and summary statistics of the 12 participating general practices compared with English averages
General
practice
List size* Mean age 
in years†
Age ≥ 65 years 
n (%)‡
Gender:
Male n (%)  
Female n (%)†
Ethnicity: 
non-White ethnic 
groups n (%)§
Index of Multiple
Deprivation‖
(Decile)
  Rural/
urban¶
CQC safety
rating**
CQC overall
rating**
A 23687 42.59 4937 (21.0) 11497 (48.9)12014 (51.1) 611 (2.6) 10.1 (9) Rural Good Good
B 6780 37.03 1021 (15.3) 3123 (46.8)3551 (53.2) 1041 (15.6) 45.0 (1) Urban Good Good
C 4128 39.18 535 (13.2) 2113 (52.1)1942 (47.9) 965 (23.8) 26.9 (4) Urban Good Outstanding
D 9533 41.24 1724 (17.8) 4756 (49.1)4931 (50.9) 436 (4.5) 18.3 (7) Urban Good Good
F 8044 34.76 735 (8.7) 4070 (48.2)4373 (51.8) 4120 (48.8) 28.2 (4) Urban
Requires
Improvement Good
G 7311 31.45 541 (7.5) 3592 (49.8)3621 (50.2) 2936 (40.7) 55.5 (1) Urban
Requires
Improvement Good
H 3841 34.90 218 (5.1) 2205 (51.5)2077 (48.5) 1494 (34.9) 23.3 (5) Urban Good Good
I 6636 37.18 814 (13.2) 3181 (51.6)2983 (48.4) 1467 (23.8) 26.9 (2) Urban Good Good
J 3447 47.96 980 (30.1) 1560 (47.9)1696 (52.1) 94 (2.9) 7.1 (10) Rural Good Good
K 9310 41.35 1697 (18.8) 4478 (49.6)4551 (50.4) 153 (1.7) 21.8 (6) Urban Good Good
L 5202 37.36 744 (13.4) 2676 (48.2)2875 (51.8) 983 (17.7) 22.1 (5) Urban Good Good
M 4336 33.46 326 (6.5) 2651 (52.9)2360 (47.1) 3357 (67.0) 23.2 (5) Urban Good Good
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Mean 
list 
size
(SD)*
Mean age 
in years†
(SD)
Mean % aged ≥ 
65 years (SD) ‡
% Male (SD)
% Female (SD) †
% non-White 
ethnic groups§ 
(SD)
Mean Index of 
Multiple
Deprivation‖ 
(SD)
Number 
rural/
urban¶
CQC safety 
rating**(%)
CQC overall 
rating**
percentage
All study 
practices††
7688 
(5453) 38.87 (4.03)
15.4 
(6.0)
49.4 (1.54)
50.6 (1.54)
19.0 
(19.6)
23.5
(13.2)
10 urban
2 rural
Good (83.3%)
Requires 
improvement 
(16.7%)
Good (91.7%)
Outstanding 
(8.3%)
Mean 
list 
size‡
Mean age 
in years†
% aged ≥ 65 
years‡
% Male 
% Female†
% non-White 
ethnic groups
(%)‡‡
Mean Index of 
Multiple
Deprivation‖
CQC Overall 
Rating Average**
English 
average
7586 39.85 17.2 49.83
50.17
14.0 21.8
For all English practices, the 
Overall rating was: 
Outstanding (4.1%); Good 
(84.2%); Requires 
Improvement (9.1%); 
Inadequate (2.6%)§§
*Taken from NHS Digital on 01-04-2015 http://digital.nhs.uk/catalogue/PUB17356
†Taken from NHS Digital April 2017. https://digital.nhs.uk/catalogue/PUB23475
‡For 2016 Accessed from Public Health England National General Practice Profiles. http://fingertips.phe.org.uk/profile/general-practice/data
§Taken from 2011 Census. Accessed from Public Health England National General Practice Profiles. http://fingertips.phe.org.uk/profile/general-practice/data
‖Index of Multiple Deprivation 2015. Accessed from Public Health England National General Practice Profiles. http://fingertips.phe.org.uk/profile/general-practice/data
¶Taken from the 2011 census figure for the population of the city or town where the practice was located. 
**Taken from Care Quality Commission (CQC) on February 2017  http://www.cqc.org.uk/what-we-do/services-we-regulate/doctorsgps
††The practice average and standard deviation use values that are weighted by the practice list size. 
‡‡Taken from 2011 Census. https://www.ons.gov.uk/peoplepopulationandcommunity/culturalidentity/ethnicity/articles/ethnicityandnationalidentityinenglandandwales/2012-12-11
 §§As of the end of February 2017
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Table 2: Avoidability of the 2131 new significant health problems identified by the first 
GP data collector
Avoidability classification                                                                            Number (%)
Totally avoidable: Virtually certain evidence of avoidability 0 (0.0)
Probably avoidable: Strong evidence of avoidability 14 (0.7)
Probably avoidable: Probably avoidable, > 50:50, but close call 18 (0.8)
Possibly avoidable: Possibly avoidable, <50:50, but close call 19 (0.9)
Unavoidable: Slight to modest evidence of avoidability 16 (0.7)
Totally unavoidable: Virtually no evidence of avoidability (based on study 
team avoidability assessment)
10 (0.5)
Totally unavoidable: Virtually no evidence of avoidability (based on GP 
assessment that there had been an ‘adequate standard of care’)
2054 (96.4)
Total                                                                                                                  2131    (100)
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Table 3: Summary of cases judged by the study team to have significant harm with at 
least slight to modest evidence of avoidability
Avoidability rating following moderation of all cases by the 
study team
Cases
Slight to 
modest 
evidence of 
avoidability
Possibly 
avoidable, 
<50–50, 
but close 
call
Probably 
avoidable, 
>50–50, 
but close 
call
Strong 
evidence of 
avoidability
Virtually 
certain 
evidence of 
avoidability
Total
Cases from enhanced 
sample
(1st GP data collector)
16 19 18 14 0 67
Additional cases from 
10% sample of 
enhanced sample
(2nd GP data collector)
2 2 1 1 0 6
Additional case from 
2.5% sample (not from 
enhanced sample)
1 0 0 0 0 1
Total 19 21 19 15 0 74
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Table 4: Distribution of different types of primary incidents
Types of primary incident:  
incidents occurring proximal 
(chronologically) to the patient 
outcome
At least slight 
to modest 
evidence of 
avoidability
n (%)
At least possible 
evidence of 
avoidability
n (%)
At least 
probable 
evidence of 
avoidability
n (%)
Diagnostic errors 45 (60.8) 34 (61.8) 22 (64.7)
Wrong diagnosis – original 
diagnosis is found to be 
incorrect because the true 
cause is discovered later.
16 (21.6) 13 (23.6) 11 (32.4)
Delayed diagnosis (non-cancer) 
– diagnosis could have been 
made earlier if care was 
evidence-based.
21 (28.4) 15 (27.3) 10 (29.4)
Delayed cancer diagnosis 8 (10.8) 6 (10.9) 1 (2.9)
Medication errors 19 (25.7) 13 (23.6) 6 (17.6)
No drug treatment given 4 (5.4) 3 (5.4) 2 (5.9)
Insufficient drug treatment given 4 (5.4) 4 (7.3) 1 (2.9)
Prescribing errors 6 (8.1) 4 (7.3) 1 (2.9)
Monitoring errors 2 (2.7) 2 (3.6) 2 (5.9)
Adverse drug reaction 1 (1.3) -  -  
Medication not commenced in a 
timely manner 1 (1.3) -  -  
Vaccine administration 1 (1.3) -  -  
Referral errors 8 (10.8) 7 (12.7) 6 (17.6)
Delayed referral 7 (9.4) 6 (10.9) 6 (17.6)
Referral not performed when 
indicated 1 (1.3) 1 (1.8) -  
Other 2 (2.7) 1 (1.8) -  
Patient communication not sent 
from secondary to primary care 1 (1.3) 1 (1.8) -  
Incorrect test ordered 1 (1.3) -   -  
Total (%) 74 (100) 55 (100) 34 (100)
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Box 3. Examples of avoidable significant harm 
30-week delay in diagnosing throat cancer (avoidability rating: 5; strong evidence of 
avoidability)
A middle-aged patient attended the GP with a hoarse voice and difficult swallowing. He 
reported that his mouth felt like the time he had thrush which required a referral to a 
gastroenterologist for an endoscopy and it eventually settled with an anti-fungal medication. 
In the medical records the GP described signs of oral thrush in the mouth and wrote, ‘if does 
not settle, consider oral treatment or referral back to gastroenterologist’. Over the next 19 
weeks the patient returned, with six visits to the original and different GPs, with on and off ‘red 
flag’ symptoms that were either improving or worsening or of varying intensity (hoarseness, 
swallowing issues, odd breathing pattern, difficulty talking, sensation of a lump in throat) and 
each time was given a course of anti-fungal medication. From week 12, the medical records 
describe ‘food getting stuck’. At week 15, a referral for endoscopy was made and the patient 
was seen one week later. At this point, the patient informed the gastroenterologist he was 
losing weight. No abnormalities were seen on endoscopy and the patient was told to go back 
to his GP and have his hoarse voice investigated further (with the same advice in a letter to 
the GP). Four weeks later the patient was seen by the GP and a non-urgent referral to ENT 
was made. At week 30 the patient was seen by ENT and a rare type of neck cancer was 
diagnosed requiring chemotherapy.
Seven-year delay in diagnosis of prostate cancer (avoidability rating: 4; probably 
avoidable, more than 50:50, but close call)
An elderly patient with Type 2 diabetes mellitus attended a nurse appointment stating that he 
was experiencing nocturnal frequency. It was suspected this was due to poorly controlled 
diabetes and amendments to his medication regime were made. Six weeks later, the patient 
had a telephone consultation with the GP, since he was concerned about weight loss, a loss 
of appetite, increased urinary frequency and night cramps. He was booked with the GP for a 
face-to-face consultation the following day. It was also noted he had a weight loss of 2-3Kg, 
he was urinating at least 5-6 times per night, and he felt nauseous. The GP felt the signs and 
symptoms were related to poorly controlled diabetes and arranged for the patient to be 
reviewed by the practice nurse. Over the next week, blood tests (glycosylated haemoglobin 
and ‘urea and electrolytes’ (U&E)) and urine analysis were undertaken, and his anti-
hyperglycaemic medications were amended. The nurse followed the patient up a few days 
later, where a further drop in weight was noted. The patient reported some improvement in 
symptoms since he was now getting up at night to pass urine four instead of six times. The 
nurse advised a follow-up appointment with the GP, which did not occur until four weeks later. 
At this time, the GP noted the patient had seven years previously had a raised prostate specific 
antigen (PSA). However, the patient had been unable to tolerate a biopsy for a definitive 
diagnosis, so six-monthly PSA testing was advised; however, the patient did not have a follow-
up PSA in the subsequent seven year period. On noting this, the GP advised the patient to 
have a PSA test which was undertaken three weeks later. The PSA measured very high (>100 
ng/mL). The patient had a GP appointment one week later when he was informed his PSA 
was raised. An urgent ‘suspected cancer’ referral was made. He was seen by a urologist the 
following week and diagnosed with localised prostate cancer requiring a transurethral 
resection of the prostate.
16-month delay in diagnosing non-insulin dependent diabetes mellitus (Avoidability 
rating: 3; possibly avoidable, less than 50-50, but close call)
An impaired fasting glucose was identified in a middle-aged patient and was followed up with 
a glucose tolerance test (GTT). The patient was seen by GP (A) soon after and was informed 
the GTT revealed an impaired glucose tolerance and was given dietary and lifestyle advice. 
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The patient was told to have a repeat test four months later. The patient was seen four months 
later by a different GP (B); however, the focus of the consultation was on yellow sclerae and 
liver function tests (LFTs) were ordered. A test to assess diabetes was not requested. The 
patient presented two months later with weight loss, and GP (B) referred the patient for an 
endoscopy and a repeat liver function test. A follow-up telephone call one month later occurred 
to discuss the LFTs with GP (B). Three months later, the patient presented to GP (B) with 
tiredness and fatigue. Again, blood tests were requested but did not include tests for diabetes. 
Six months later, a blood glucose was undertaken as part of an annual review and following 
two fasting blood glucose tests one week apart, poorly controlled non-insulin dependent 
diabetes mellitus was diagnosed.
Four-month delay in referral for an ischaemic limb (avoidability rating: 5; strong 
evidence of avoidability)
A patient in his early 60s stubbed his big toe three weeks prior to attending a nurse 
appointment at the general practice. The patient was known to have cardiovascular disease 
including hypertension (prescribed two antihypertensives) and raised cholesterol (prescribed 
a statin). The nurse noted the toe was bruised, painful, red and had a foul odour. The patient 
was prescribed antibiotics for a presumed infection and a referral was made to podiatry for 
removal of an associated in-growing toenail. Four weeks later, a podiatrist was unable to 
detect a dorsalis pedis or posterior tibial pulse in the affected foot and the patient was advised 
to see a GP urgently. The patient was reviewed by the GP and a referral to a vascular surgeon 
was discussed, but not made. Instead a further consultation with the same GP in four weeks 
was agreed, with regular nursing reviews of wound healing in the interim. At the first follow up 
nurse review one week later, the nurse noted that the toe was healing, but there were no 
pulses with the Doppler scan, and that the patient informed the nurse he needed to sleep with 
the foot outside the bed because it was so painful. The GP saw him three days later and 
decided to make a non-urgent vascular referral, but the letter was not sent to the vascular 
surgeons for six weeks. The patient was seen in a vascular clinic nearly four months after the 
podiatrist noted absent pulses and was informed that he had critical leg ischaemia and needed 
surgery. He underwent a right superficial femoral artery (SFA) and posterior tibial artery (PTA) 
stent four weeks later. Some nine months later, he required amputation of his big toe and 
second digit. 
Long-term nephrotoxic medications in older adults
We observed two cases where patients with known reduced kidney function were receiving 
long-term potentially nephrotoxic drugs. One of the patients was prescribed naproxen ‘as 
required’ for gout but received a twice daily monthly supply for >12 months whilst 
concurrently receiving long-term nitrofurantoin. A hospital admission for acute-on-chronic 
kidney injury was required (avoidability rating: 5; strong evidence of avoidability).
Another patient was taking lithium and should have had three-monthly U&E blood tests to 
monitor their kidney function. This did not happen for 15 months and the patient was admitted 
with acute kidney injury  (avoidability rating: 4; probably avoidable, more than 50:50, but 
close call).
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Box 4. Underlying incidents resulting in delayed diagnoses (history taking, 
examination, investigation, communication and referral)
 Incomplete history taking (one case), e.g. not enquiring about red flags and not 
documenting salient negatives, inaccurate medical records (two cases), and inadequate 
documentation of care delivered (one case). 
 Absent or delayed physical examination (five cases), e.g. advising patient to book 
another visit to undertake a pelvic examination. 
 Not ordering correct investigations (three cases), e.g. no follow up or investigations 
ordered for an older adult with a three-week history of diarrhoea with blood and mucous; 
the patient eventually required an emergency admission and Crohn’s disease was 
diagnosed. 
 Failing to order a necessary investigation (one case), e.g. not testing for diabetes 
mellitus when presenting with lower urinary tract symptoms. 
 Inappropriate responses to laboratory (three cases) or imaging (one case) investigations, 
e.g. i) not recognising the cut off for diagnosing Type 2 diabetes; ii) not arranging a 
follow-up chest x-ray (that had been advised by a radiologist) in a patient with an opacity 
seen on serial radiographs (this resulted in a delay in referral to respiratory medicine for 
an eventual diagnosis of lung cancer). 
 Transfer of information about the patient which included delays in the communication 
being sent (two cases) or not sent at all by secondary care (one case), or a 
communication received but not actioned in primary care (three cases). 
 Incorrect advice being given to the patient (one case), e.g. patient with insulin-dependent 
diabetes not given information about how to prepare for an endoscopy and GP did not 
inform secondary care the patient was diabetic. 
 Delayed referral (seven cases), referral not made (one case) or referral sent to the wrong 
location.
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Table 5: Distribution of contributory factors
Types of contributory factor: 
circumstances, actions or influences which 
are thought to have played a part in the 
origin or development, or to increase the 
risk, of a patient safety incident46
At least slight 
to modest 
evidence of 
avoidability
n (%)
At least 
possible 
evidence of 
avoidability
n (%)
At least 
probable 
evidence of 
avoidability
n (%)
Patient factors 82 (71.9) 59 (69.4) 32 (68.1)
   Multimorbidity: patient has two or     
   more chronic medical conditions 20 (17.5) 15 (17.6) 11 (23.4)
   Co-morbidity: the presence of one or 
   more additional diseases 8 (7.0) 5 (5.9) 3 (6.4)
   Rare presentation: an uncommon 
   pattern of signs or symptoms  8 (7.0) 5 (5.9) 3 (6.4)
   Previous medical / medication history 8 (7.0) 5 (5.9) 3 (6.4)
   Patient age 7 (6.1) 6 (7.1) 3 (6.4)
   Pathophysiological factors: the 
   patient’s physical and medical well-     
   being and health inclusive of frailty
6 (5.3) 5 (5.9) 3 (6.4)
   Clinician perception of patient behaviours: 
the way in which patients or caregivers 
act towards clinicians
6 (5.3) 5 (5.9) 1 (2.1)
   Response to medical advice: patient 
   does not appear to follow the advice 
   or instructions given by the clinician
6 (5.3) 4 (4.7) -   
   Complex agenda: patient presents 
   with multiple issues in a single 
   consultation
4 (3.5) 3 (3.5) 1 (2.1)
   Medication taking: patient does not 
   appear to take medication as 
   prescribed
2 (1.8) 2 (2.4) -  
   Clinical history taking: problems with 
   eliciting relevant information 2 (1.8) 1 (1.2) 1 (2.1)
   Language: patient unable to 
   communicate in English 2 (1.8) 2 (2.4) 2 (4.3)
   Disability: a physical or mental 
   condition that limits a person’s 
   movements, senses, or activities
2 (1.8) 1 (1.2) 1 (2.1)
   Does not leave the house or home 1 (0.9) -  -
Staff factors 8 (7.0) 7 (8.2) 5 (10.6)
   Inadequate knowledge/skill set 6 (5.3) 6 (7.1) 4 (8.5)
   Mistake 2 (1.8) 1 (1.2) 1 (2.1)
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Types of contributory factor: 
circumstances, actions or influences which 
are thought to have played a part in the 
origin or development, or to increase the 
risk, of a patient safety incident46
At least slight 
to modest 
evidence of 
avoidability
n (%)
At least 
possible 
evidence of 
avoidability
n (%)
At least 
probable 
evidence of 
avoidability
n (%)
Organisational issues 24 (21.1) 19 (22.4) 10 (21.3)
   Continuity of care across system: 
   problem with the delivery of a 
   'seamless service' through 
   integration, coordination and the 
   sharing of information between 
   different providers
8 (7.0) 8 (9.4) 4 (8.5)
   Continuity of care within primary care: 
   seen by multiple members of team 
   within the same practic  
6 (5.3) 3 (3.5) 1 (2.1)
   Continuity of care between secondary 
   and primary care: lack of coordinated 
   care
2 (1.8) 1 (1.2) -  
   Protocols/ policies/ 
   standards/guidelines inadequate, 
   inefficient, absent or not available 
   (specific problems noted below) 
2 (1.8) 1 (1.2) 1 (2.1)
   Investigations 2 (1.8) 2 (2.4) 1 (2.1)
   Repeat prescribing 1 (0.9) 1 (1.2) 1 (2.1)
   Referral 1 (0.9) 1 (1.2) -   
   Locum or agency staff 1 (0.9) 1 (1.2) 1 (2.1)
   Waiting lists for ‘urgent’ referrals 1 (0.9) 1 (1.2) 1 (2.1)
Total (%) 114 (100) 85 (100) 47 (100)
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Supplementary materials
Incidence, nature and causes of avoidable significant harm in primary care in 
England: retrospective case note review
Details of methods used in the study
Our study protocol describes the methods we employed in detail.1 Box 1 in the main 
manuscript provides the definitions used in the study.The study had NHS research ethics 
committee approval (15/EM/0411), Confidentiality Advisory Group (CAG) support under 
section 251 to process patient identifiable information without consent (15/CAG/0182) and 
Research and Development (R&D) approvals. 
Participants
We undertook a retrospective case note review of an open cohort of all primary care patients 
registered with participating general practices (between 1 April 2015 and 31 March 2016) to 
identify cases of avoidable significant harm. The study took place in 12 general practices 
from three different areas of England: East Midlands (n=7), Greater London (n=2) and 
Greater Manchester (n=3). The East Midlands and Greater Manchester were chosen for 
convenience as this is where most of the English members of our team are based. London 
was selected to provide geographical and demographic balance.
General practices were eligible to participate if they pro ided written informed consent, 
delivered NHS services, had electronic health records and used one of the three main 
computer systems in England (i.e. EMIS Web, TPP SystmOne, or INPS Vision). General 
practices were excluded from the study if they were involved in a major reorganisation (such 
as a merger with another practice) between 1 April 2015 and 31 March 2016 since this 
would have made it difficult to identify the practice list size for the retrospective case note 
review.
We aimed to sample general practices with characteristics representative of English 
practices as a whole, with a total population of up to 100,000. This figure was based on a 
pilot study, which demonstrated that this was the largest sample we could manage within the 
substantial available funding, whilst also conducting the study to a high standard. We 
estimated the precision of our study based on different possible rates of avoidable significant 
harm. For example, for a rate of avoidable significant harm of 40 per 100,000 patients per 
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year, the precision (based on 95% confidence intervals) was estimated to be between 28 
and 52 per 100,000 patients per year. 
From the three regions, we identified a total of 757 practices: East Midlands (n=266), 
Greater London (n=366) and Greater Manchester (n=125).  We used stratified random 
sampling to identify the general practices to approach.  Firstly, the practices from each area 
were stratified by list size into quartiles, with list sizes taken from the NHS Digital website.2 
Secondly, the practices from each area and each quartile were listed in computer-generated 
random order. We then selected the 80 practices appearing at the top of the stratified 
random lists, consisting of 40 practices from the East Midlands (10 practices in each 
quartile) and 20 practices from each of Greater London and Greater Manchester (five 
practices in each quartile). Practices were over-recruited from the East Midlands given most 
of the GPs recruited for data collection were based in this region.
We emailed and/or wrote to general practices (via the practice manager and general 
practitioners within the practices) inviting participation. We used a range of approaches to 
encourage participation, including prior publicity about the study, engaging local opinion 
leaders and providing reassurance about data confidentiality. Of the 80 practices 
approached, 12 were included in the study (see Figure 1).
Patients in the practices were excluded if they had a computer code in their clinical records 
indicating that they did not wish to be included in research studies. Patients were also 
excluded if they completed an opt-out form. 
Recruitment and training of data collectors
General practitioners with at least five years’ experience in general practice were recruited to 
collect data from the participating practices. These GPs were recruited from the East 
Midlands, Greater Manchester and Greater London via the Royal College of General 
Practitioners and existing contacts. Thirteen general practitioners were recruited and trained 
to ensure a consistent approach to identifying and classifying patients with avoidable 
significant harm. Further details are provided in our protocol paper.1 
Sampling of patient records
We sampled patient records in three stages. In Stage 1, we identified the total patient 
population of the practices at the start of the retrospective cohort. In Stage 2, we identified 
patients at increased risk of avoidable significant harm (the ‘enhanced sample’), and in 
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Stage 3, we identified those from Stage 2 who had experienced a significant new health 
problem during the 12-month retrospective review period.
The population for Stage 1 comprised those patients registered with the 12 general practices 
at the start of the retrospective cohort (1 April 2015). To identify patients at increased risk of 
avoidable significant harm (Stage 2), we drew upon suggestions made by the research 
commissioners, (the National Institute for Health Research (NIHR) Policy Research 
Programme), the literature on avoidable harm in primary care3 and our own experience of 
inductively analysing reports of harm associated with primary care in the National Reporting 
and Learning System (NRLS).4 We included patients with characteristics considered to be 
associated with significant health problems and/or increased risk of patient safety incidents. 
The identification of pati nts with a higher likelihood of significant health problems allowed 
us to focus on those cases where any avoidable harm was likely to be significant too. We 
included those who had: died5 or had been admitted to hospital or a mental health facility6 as 
these were likely to have experienced a significant health problem; those that were resident 
in a care home as they were likely to have significant health problems and increased risk of 
medication errors;7 those that had 10 or more repeat medications,8,9 as they were at greatest 
risk of harm from medication error; those with four or more major morbidities as our previous 
study had shown multi-morbidity to be associated with avoidable harm;5 those that had 
undergone an invasive procedure in general practice, such as a minor operation as safety 
concerns have been raised about this10 and those that had been certified unfit for work long-
term, as this was suggested by our funder, as it might have resulted from an avoidable 
harm. 
Electronic registry queries at each practice (for 12 months from the start of the retrospective 
cohort) identified these patients who formed the ‘enhanced sample’. Search strategies were 
developed and tested for the medical record systems of participating practices. This was an 
iterative process aimed at identifying 10-15% of the population for the enhanced sample and 
influenced the choice of four or more comorbidities and 10 or more repeat medications 
(smaller numbers of each would have resulted in an enhanced sample that was too large for 
the resources available for detailed records review). 
The approach we used was different to that used in trigger tool methods11 as were trying to 
identify a sample for detailed case note review, whereas trigger tool methods are applied to 
a patient sample that has already been selected. There was overlap in the criterion of 
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hospital admissions, for example,11 but other ‘triggers’ (such as repeat medication 
discontinued) would have identified too many patients.
We also asked the participating general practices to identify any patients they knew who had 
experienced avoidable harm, e.g. based on significant event analyses;12 this did not identify 
any additional patients but some practices did not engage in providing this information to 
reviewers. 
The next stage of sampling (Stage 3) identified patients with significant health problems 
(irrespective of whether these were avoidable or not). It involved one of the GP data 
collectors screening the electronic health record of each patient in the ‘enhanced sample’ to 
identify any new significant health problems experienced by patients over the 12 months of 
the study (1 April 2015 – 31 March 2016); this included all deaths. The research team 
provided the GP data collectors with detailed guidance on the significant health problems we 
wanted to screen for; this included all new major physical and psychiatric morbidities, and 
accidents (with examples including acute kidney injury, asthma requiring hospital admission, 
cancer, diabetes mellitus (including serious complications), deep vein thrombosis, heart 
failure, myocardial infarction, pulmonary embolism, and stroke). The GPs then undertook 
detailed retrospective reviews of the records of this final sample of patients to identify the 
extent to which errors of omission (e.g. failures of prevention) or commission in primary 
healthcare provision contributed to any of these significant health problems. 
For the purposes of sensitivity analysis (recognising that cases might have been missed by 
our sampling approach), the GP data collectors also undertook a detailed records review for 
the following:
 2.5% random sample of the Stage 1 population, but not including patients identified for 
the Stage 2 enhanced sample; each record was examined by a single GP reviewer.
 10% random sample of the Stage 2 enhanced sample; each record was examined by a 
second GP reviewer.
Variables
For participating general practices we obtained data on the following variables: list size 
(number of patients); age distribution (particularly highlighting the number and percentage of 
patients aged 65 years and older); number and percentage of males and females; ethnicity 
(number and percentage of non-White patients); Index of Multiple Deprivation (IMD), the 
official measure of deprivation in England; whether practices were rural or urban; Care 
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Quality Commission (CQC) overall rating for the practices, and CQC safety rating for the 
practices. The CQC is an independent regulator health and adult social care service 
providers in England and responsible for checking through inspection and ongoing 
monitoring that care quality and safety standards are being met.13 In addition, for each 
practice we calculated the number of patient-years of data available for the period 1 April 
2015 to 31 March 2016 using registration data. 
Identification of avoidable significant harm, and factors associated with this
For those patients with significant health problems, the GP data collectors reviewed the 
patient records and recorded whether they considered that the patient had received an 
adequate standard of care for these problems, or whether there was any evidence of 
avoidable harm. For the latter cases, the GPs provided a detailed written account of the 
principal problem in the patient’s primary care that led to the significant health problem, a 
narrative describing the manner in which the significant health problem could have 
potentially been prevented within primary care, and a judgement on the avoidability of the 
significant health problem using a validated six-point scale (see Box 2 of the main 
manuscript).14,15 The GP data collectors searched back in patients’ records as far as was 
needed to establish whether the significant health problem was avoidable or not. The 
evidence recorded by the GP data collectors was typically descriptions of salient signs or 
symptoms, pertinent past or concurrent medical or psychosocial history detail, and/or the 
actions or plans recorded by GPs in entries for each clinical encounter. Such descriptions 
were essentially 'signals' in the case note entries identified by the reviewers informing 
judgements about avoidability. 
All cases were considered in detail by the study team, and the GP data collectors were 
asked to provide additional information if any clarification were needed. Each case was 
discussed by the study team and we considered what additional evidence (or signals) we 
would be seeking in the case notes in order to justify the avoidability score awarded, or to 
upgrade or downgrade the score. During those discussions, a member of the study team 
had online access to published guidelines to ensure our study team judgements were 
compliant with best practice guidelines. If relevant guidelines had been published since the 
observed study period, we considered the evidence available at that time. Where there was 
an absence of published guidelines, we considered trial data or systematic reviews 
(particularly Cochrane reviews). If necessary, we asked the GP data collector to return to the 
relevant general practice to examine the clinical records again to confirm the presence or 
absence of the evidence the study team deemed relevant to inform final judgements about 
avoidability. GPs only recorded what was explicitly stated in the records, or described what 
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was evidently absent in relation to what would be expected based on relevant guidelines for 
the condition. To ensure consistency the study team made the final judgement, through 
consensus, in terms of the classification of avoidable significant harm. 
Data collection and coding
Each of the participating general practices was visited by an informatician from the study 
team who collected baseline data on the practice population and ran a computer search to 
identify patients for the enhanced sample and for the sensitivity analyses. Using encrypted 
tablet computers and a Virtual Private Network (VPN) connection, the GP data collectors 
entered anonymised data directly into a database on a secure server at Cardiff University. 
The nature of the avoidable harm was recorded by the GP data collectors using the 
comprehensive patient safety classification system developed in the Primary Care Patient 
Safety Classification (PISA) study.16 The classification system has been empirically derived 
and aligned to the WHO International Classification for Patient Safety using a constant 
comparative approach.17 The system has been used for analysis of over 72,000 patient 
safety incident reports from NHS organisations in England and Wales for 26 major studies of 
patient safety predominantly in primary care.18-33 
Case narratives were deconstructed using codes from the classification system to describe: 
incident types (primary and contributory); potential contributory factors which are 
circumstances, actions of influences that played a part in the origin or development of the 
incident; incident outcomes; and harm severity. Primary incidents included those proximal 
(chronologically) to the patient outcome, whereas contributory incidents included those that 
contributed to the occurrence of another incident. Multiple codes for incident type (e.g. 
administration, medication), contributory factor (e.g. patient co-morbidity, staff workload), 
and incident outcome were applied to each case where necessary. The codes were applied 
systematically and chronologically 16,34.
Analysis
We estimated the incidence of significant harm that was considered at least probably 
avoidable (our primary outcome – avoidability score 4 or more) and at least possibly 
avoidable (avoidability score 3 or more) and expressed these as ‘per 100,000 patient-years’ 
accompanied by 95% confidence intervals (95% CI).1 We assessed inter-rater reliability of 
judgements made by paired GP data collectors using the Cohen’s Kappa statistic (with 95% 
CI). 
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Members of the study team then undertook a detailed analysis of the information provided 
on each case of potentially avoidable significant harm and included cases with at least ‘slight 
to modest’ (score 2 or more) evidence of avoidability, as we judged that even in these cases 
there were important insights. This included in-depth case analysis meetings, also involving 
team members with patient and public involvement background (ACh and AD). We reviewed 
and discussed the cases with the purpose of identifying commonalities and differences 
between them. We analysed the data recorded on the cases and examined the relationships 
between different types of incident and the factors that contributed to these incidents. As a 
result, we identified the most important factors contributing to avoidable significant harm.
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